Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2002 Jun;61(6):560–561. doi: 10.1136/ard.61.6.560

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

G Triolo, M Vadala, A Accardo-Palumbo, A Ferrante, F Ciccia, E Giardina, P Citarrella, G Lodato, G Licata
PMCID: PMC1754121  PMID: 12006336

Full Text

The Full Text of this article is available as a PDF (117.3 KB).

Figure 1 .

Figure 1

(A) Fluorescein angiography obtained at admission, showing a hyperfluorescent optic disc in both eyes, diffuse irregular mottled retinal hyperfluorescence, and haemorrhagic hypofluorescence in the left eye. (B) Fluorescein angiography obtained before the third infusion, showing a normal optic disc aspect, improvement of macular oedema in the right eye and still in the mottled aspect of retinal capillary filling.


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES